Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 201

Results For "US"

8882 News Found

Arzeda closes US$33 million Series B funding
Digitisation | April 01, 2022

Arzeda closes US$33 million Series B funding

Arzeda harnesses the power of computer-designed enzymes and applies the latest advances in digital biology


USFDA seeks more analysis on Merck’s BLA for Vaxneuvance
Biotech | April 01, 2022

USFDA seeks more analysis on Merck’s BLA for Vaxneuvance

No new studies have been requested


FDI World Dental Federation releases statement on sustainable oral healthcare
Sustainability | March 31, 2022

FDI World Dental Federation releases statement on sustainable oral healthcare

It paves the way for an industry Code of Good Practice


HealthQuad raises US $ 162 million in second fund
Startup | March 31, 2022

HealthQuad raises US $ 162 million in second fund

The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe


Symbiance announces the launch of SimpleStats to help pharma and biotech industries
Digitisation | March 31, 2022

Symbiance announces the launch of SimpleStats to help pharma and biotech industries

It is an application to automate statistical analysis and reporting for clinical research.


Phablecare acquires Fused Training, a startup combating Type-1 Diabetes
Startup | March 31, 2022

Phablecare acquires Fused Training, a startup combating Type-1 Diabetes

Phablecare closed this acquisition for an undisclosed sum, betting on the start-up's holistic approach to Type 1 Diabetes management


USFDA approves Edwards Mitris Resilia valve
Medical Device | March 31, 2022

USFDA approves Edwards Mitris Resilia valve

The valve has a saddle-shaped sewing cuff that mimics the asymmetric shape of the native mitral valve


Sun Pharma gets exclusive patent licence for Vortioxetine
News | March 30, 2022

Sun Pharma gets exclusive patent licence for Vortioxetine

Vortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in adults


USFDA approves CartiHeal's implant for the treatment of cartilage and osteochondral defects
Drug Approval | March 30, 2022

USFDA approves CartiHeal's implant for the treatment of cartilage and osteochondral defects

Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of Agili-C™ implant to the current surgical standard of care, debridement and microfracture in the knee joint


Ozempic 2.0 mg approved in the US for the treatment of type 2 diabetes
Drug Approval | March 29, 2022

Ozempic 2.0 mg approved in the US for the treatment of type 2 diabetes

Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults